Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion type Assertion NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_head.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion description "[In tumor cells, PRL-3 mRNA levels varied markedly with high expression in SKNAS neuroblastoma, MCF-7 and BT474 breast carcinoma, Hep3B hepatocellular carcinoma, and HCT116 colon carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_provenance.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion evidence source_evidence_literature NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_provenance.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion SIO_000772 16505094 NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_provenance.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion wasDerivedFrom befree-20150227 NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_provenance.
- NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_assertion wasGeneratedBy ECO_0000203 NP860928.RAY2NEOsAa7KDVrDkT6DE_U_gxKyvjkIe8GDsUfFvB0Nk130_provenance.